Evidence map›Paper›PMID 24259584›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

Remote optogenetic activation and sensitization of pain pathways in freely moving mice.

Ihab Daou, Alexander H Tuttle, Geraldine Longo, Jeffrey S Wieskopf, Robert P Bonin, Ariel R Ase, John N Wood, Yves De Koninck, Alfredo Ribeiro-da-Silva, Jeffrey S Mogil and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 184 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  6. Article
  7. Article
  8. A NaFrontiers in molecular neuroscience · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Optogenetic and Chemogenic Control of Pain Signaling: Molecular Markers.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Peripheral mechanisms of peripheral neuropathic pain.Frontiers in molecular neuroscience · 2023
    Review
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Ihab DaouMontreal Neurological Institute, Department of Neurology and Neurosurgery, The Alan Edwards Centre for Research on Pain, and Departments of Psychology and Pharmacology and Therapeutics, McGill University, Montreal, Canada, H3A 2B4, Quebec Mental Health Institute, Department of Psychiatry and Neuroscience, Laval University, Quebec City, Canada, G1J 2G3, and Wolfson Institute for Biomedical Research, University College London, London, United Kingdom, WC1E 6BT.
Alexander H Tuttle
Geraldine Longo
Jeffrey S Wieskopf
Robert P Bonin
Ariel R Ase
John N Wood
Yves De Koninck
Alfredo Ribeiro-da-Silva
Jeffrey S Mogil
Philippe Séguéla
Edwards (United Kingdom) · GBEdward Hospital · USInstitut Universitaire en Santé Mentale de Québec · CAMcGill University · CAUniversité Laval · CAUniversity College London · GB

Funding

Arthritis Research UK 20200CIHR MOP12942CIHR MOP79411CIHR MOP86527Wellcome Trust 101054
6 · The paper itself

Abstract

We report a novel model in which remote activation of peripheral nociceptive pathways in transgenic mice is achieved optogenetically, without any external noxious stimulus or injury. Taking advantage of a binary genetic approach, we selectively targeted Nav1.8(+) sensory neurons for conditional expression of channelrhodopsin-2 (ChR2) channels. Acute blue light illumination of the skin produced robust nocifensive behaviors, evoked by the remote stimulation of both peptidergic and nonpeptidergic nociceptive fibers as indicated by c-Fos labeling in laminae I and II of the dorsal horn of the spinal cord. A non-nociceptive component also contributes to the observed behaviors, as shown by c-Fos expression in lamina III of the dorsal horn and the expression of ChR2-EYFP in a subpopulation of large-diameter Nav1.8(+) dorsal root ganglion neurons. Selective activation of Nav1.8(+) afferents in vivo induced central sensitization and conditioned place aversion, thus providing a novel paradigm to investigate plasticity in the pain circuitry. Long-term potentiation was similarly evoked by light activation of the same afferents in isolated spinal cord preparations. These findings demonstrate, for the first time, the optical control of nociception and central sensitization in behaving mammals and enables selective activation of the same class of afferents in both in vivo and ex vivo preparations. Our results provide a proof-of-concept demonstration that optical dissection of the contribution of specific classes of afferents to central sensitization is possible. The high spatiotemporal precision offered by this non-invasive model will facilitate drug development and target validation for pain therapeutics.

Indexed as

OptogeneticsAfferent PathwaysAnimalsAvoidance LearningCells, CulturedChannelrhodopsinsFemaleGanglia, SpinalGreen Fluorescent ProteinsHyperalgesiaIn Vitro TechniquesMaleMiceMice, Inbred C57BLMice, TransgenicMorphine2-amino-5-phosphopentanoic acidChannelrhodopsinsenhanced green fluorescent proteinGreen Fluorescent ProteinsMorphineNAV1.8 Voltage-Gated Sodium ChannelReceptors, Purinergic P2X3Scn10a protein, mousetau ProteinsValine

Identifiers

PMID24259584
PMCPMC6618811
OpenAlexW2029105646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.